F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
FDA OKs New Keytruda Shot for Cancernews2025-09-19T20:43:52+00:00September 19th, 2025|The New York Times|
The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chippernews2025-02-11T12:19:17+00:00February 11th, 2025|The New York Times|
Drug Company to Share Revenues With Indigenous People Who Donated Their Genesnews2025-01-07T12:03:05+00:00January 7th, 2025|The New York Times|
Pfizer Stopped Us From Getting Ozempic Decades Agonews2024-12-25T23:11:22+00:00December 25th, 2024|The New York Times|
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?news2024-11-13T10:01:57+00:00November 13th, 2024|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
Six Reasons Drug Prices Are So High in the U.S.news2024-01-17T18:53:05+00:00January 17th, 2024|The New York Times|
Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Researchnews2023-12-25T10:00:53+00:00December 25th, 2023|The New York Times|
